Grifols (GRFS) Begins Integration of Talecris Biotherapeutics
Tweet Send to a Friend
Grifols (Nasdaq: GRFS) reports that it has begun to merge its operations with Talecris Biotherapeutics in order to function as one company, following its acquisition of Talecris on June 1, 2011.
Talecris will adopt the Grifols, Inc. name as the North American corporate subsidiary of Grifols, S.A., the Spanish holding company based in Barcelona, Spain.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Talecris will adopt the Grifols, Inc. name as the North American corporate subsidiary of Grifols, S.A., the Spanish holding company based in Barcelona, Spain.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Viropharma, Inc. (VPHM) Said to Attract Acquisition Interest - Reuters
- Felcor Lodging Trst (FCH) to Sell Sheraton Suites Galleria in $21M Deal
- Microsoft (MSFT) Broke Off Talks W/ Nokia (NOK), Was Interested in Device Unit - DJ
Create E-mail Alert Related Categories
Corporate News, Mergers and Acquisitions
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
